{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:15:57Z","timestamp":1787242557864,"version":"build-2736575974"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1053\/j.ackd.2013.09.004","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T23:01:23Z","timestamp":1393887683000},"page":"134-151","source":"Crossref","is-referenced-by-count":49,"title":["Leveraging Melanocortin Pathways to Treat Glomerular Diseases"],"prefix":"10.1053","volume":"21","author":[{"given":"Rujun","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1053\/j.ackd.2013.09.004_bib1","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1681\/ASN.2005090899","article-title":"Glomerular disease workshop","volume":"16","author":"Meyers","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.mcna.2012.04.007","article-title":"Immunotherapy in renal diseases","volume":"96","author":"Kher","year":"2012","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0025-7125(05)70538-1","article-title":"Diagnosis and management of glomerular diseases","volume":"81","author":"Jennette","year":"1997","journal-title":"Med Clin North Am"},{"issue":"8","key":"10.1053\/j.ackd.2013.09.004_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneph.2012.115","article-title":"Childhood nephrotic syndrome\u2013current and future therapies","volume":"8","author":"Greenbaum","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2013.09.004_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.1981.209","article-title":"Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children","volume":"20","year":"1981","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib6","first-page":"334","article-title":"Long-term outcome of adult onset idiopathic minimal change disease","volume":"11","author":"Colattur","year":"2000","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM198901263200403","article-title":"A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy","volume":"320","author":"Cattran","year":"1989","journal-title":"N Engl J Med"},{"issue":"274","key":"10.1053\/j.ackd.2013.09.004_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/oxfordjournals.qjmed.a068422","article-title":"The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party","volume":"74","author":"Cameron","year":"1990","journal-title":"Q J Med"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9343(87)90155-0","article-title":"Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study","volume":"82","author":"Pei","year":"1987","journal-title":"Am J Med"},{"issue":"9","key":"10.1053\/j.ackd.2013.09.004_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib11","first-page":"161","article-title":"Levamisole as immunostimulant in the clinical practice","volume":"31","author":"Par","year":"1983","journal-title":"Ther Hung"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/ndt\/gfh110","article-title":"ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses","volume":"19","author":"Berg","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib13","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1523-1755.1999.00675.x","article-title":"Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy","volume":"56","author":"Berg","year":"1999","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000339287","article-title":"Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial","volume":"36","author":"Bomback","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DDDT.S17521","article-title":"Treatment of resistant nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel","volume":"5","author":"Bomback","year":"2011","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy","volume":"47","author":"Ponticelli","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrneph.2011.190","article-title":"The renaissance of corticotropin therapy in proteinuric nephropathies","volume":"8","author":"Gong","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib18","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1152\/ajpendo.00434.2002","article-title":"The melanocortin system","volume":"284","author":"Gantz","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/er.2006-0034","article-title":"Studies on the physiological functions of the melanocortin system","volume":"27","author":"Cone","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1053\/j.ackd.2013.09.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1999.tb08662.x","article-title":"The proopiomelanocortin system","volume":"885","author":"Hadley","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000216184","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis","volume":"16","author":"Papadimitriou","year":"2009","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/jcem-71-2-452","article-title":"Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man","volume":"71","author":"Veldhuis","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/PL00000868","article-title":"Melanocortin receptors: their functions and regulation by physiological agonists and antagonists","volume":"58","author":"Abdel-Malek","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/j.ackd.2013.09.004_bib25","first-page":"287","article-title":"The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation","volume":"51","author":"Cone","year":"1996","journal-title":"Recent Prog Horm Res"},{"issue":"11","key":"10.1053\/j.ackd.2013.09.004_bib26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.2008.97","article-title":"AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality","volume":"73","author":"Doi","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2013.09.004_bib27","first-page":"136A","article-title":"Adrenocorticotropin (ACTH) gel suppresses renal tubulointerstitial inflammation and injury by direct stimulation of the melanocortin 1 receptor (MC1R)","volume":"22","author":"Gong","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2012.447","article-title":"Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms","volume":"83","author":"Si","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ackd.2013.09.004_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/gut.2005.083634","article-title":"Crucial role of the melanocortin receptor MC1R in experimental colitis","volume":"55","author":"Maaser","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MNH.0b013e3280117fb5","article-title":"Cardiovascular and renal actions of melanocyte-stimulating hormone peptides","volume":"16","author":"Humphreys","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"141","key":"10.1053\/j.ackd.2013.09.004_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/adc.28.141.372","article-title":"A.C.T.H. in nephrosis","volume":"28","author":"Arneil","year":"1953","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1053\/j.ackd.2013.09.004_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2009101025","article-title":"Melanocortin 1 receptor agonists reduce proteinuria","volume":"21","author":"Lindskog","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib33","first-page":"548A","article-title":"ACTH(Acthar Gel) prevents proteinuria and renal injury in the remnant kidney: Evidence for direct podocyte protection","volume":"21","author":"Gong","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2013.09.004_bib34","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1097\/01.TP.0000144332.44435.AB","article-title":"The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity","volume":"78","author":"Lee","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib35","doi-asserted-by":"crossref","first-page":"F384","DOI":"10.1152\/ajprenal.00282.2004","article-title":"alpha-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction","volume":"290","author":"Li","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib36","doi-asserted-by":"crossref","first-page":"R560","DOI":"10.1152\/ajpregu.00279.2005","article-title":"Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney","volume":"290","author":"Ni","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib37","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.transproceed.2008.07.101","article-title":"Change of melanocortin receptor expression in rat kidney ischemia-reperfusion injury","volume":"40","author":"Lee","year":"2008","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib38","first-page":"73","article-title":"Distribution of cDNA for melanocortin receptor subtypes in human tissues","volume":"38","author":"Chhajlani","year":"1996","journal-title":"Biochem Mol Biol Int"},{"issue":"Pt 23","key":"10.1053\/j.ackd.2013.09.004_bib39","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1242\/jeb.035121","article-title":"Characterization of the sea bass melanocortin 5 receptor: a putative role in hepatic lipid metabolism","volume":"212","author":"Sanchez","year":"2009","journal-title":"J Exp Biol"},{"key":"10.1053\/j.ackd.2013.09.004_bib40","first-page":"825A","article-title":"The melanocortin receptor 1: A potential target for therapeutical drugs in nephrotic syndrome","volume":"23","author":"Elvin","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10157-009-0228-9","article-title":"Focal segmental glomerulosclerosis in a patient with isolated ACTH deficiency and reversible hypothyroidism","volume":"14","author":"Yamada","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1977.tb41843.x","article-title":"ACTH: a short introductory review","volume":"297","author":"Schwyzer","year":"1977","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib43","first-page":"250","article-title":"H.p. Acthar gel and cosyntropin review: clinical and financial implications","volume":"34","author":"Gettig","year":"2009","journal-title":"P T"},{"key":"10.1053\/j.ackd.2013.09.004_bib44","unstructured":"Berg AL. Plasma cortisol levels after natural ACTH1-39 and synthetic ACTH1-24 in humans. Paper presented at: National Kidney Foundation 2013 Spring Clinical Meetings; 2013; Poster\u00a0218."},{"issue":"9","key":"10.1053\/j.ackd.2013.09.004_bib45","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/jps.10442","article-title":"Improving pharmacokinetic properties of adrenocorticotropin by site-specific lipid modification","volume":"92","author":"Wan","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02918598","article-title":"Corticotropin in human plasma. General considerations","volume":"3","author":"Schoneshofer","year":"1984","journal-title":"Surv Immunol Res"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/acta.0.0870203","article-title":"Adrenocorticotrophin and corticosteroid changes during dexamethasone infusion to intact and synacthen infusion to hypophysectomized foetuses","volume":"87","author":"Jones","year":"1978","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0303-7207(80)90092-1","article-title":"Evidence that glycosylation of pro-opiocortin and ACTH influences their proteolysis by trypsin and blood proteases","volume":"20","author":"Loh","year":"1980","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20134","key":"10.1053\/j.ackd.2013.09.004_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF01406332","article-title":"Hypothalamic control of lipid metabolism","volume":"75","author":"Schwandt","year":"1985","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0006-291X(80)90856-6","article-title":"Stimulation of insulin secretion from mouse pancreatic islets, maintained in tissue culture, by the pituitary neurointermediate lobe of the genetically obese mouse (ob\/ob)","volume":"95","author":"Beloff-Chain","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"issue":"5897","key":"10.1053\/j.ackd.2013.09.004_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/301255a0","article-title":"Evidence that the insulin secretagogue, beta-cell-tropin, is ACTH22-39","volume":"301","author":"Beloff-Chain","year":"1983","journal-title":"Nature"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib52","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1389450033490858","article-title":"Melanocortins and their receptors and antagonists","volume":"4","author":"Voisey","year":"2003","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2011-200100","article-title":"Molecular engineering of short half-life small peptides (VIP, alphaMSH and gamma(3)MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics","volume":"71","author":"Vessillier","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/exnr.1999.7064","article-title":"alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation","volume":"157","author":"Ichiyama","year":"1999","journal-title":"Exp Neurol"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib55","first-page":"775","article-title":"A review and update on melanocyte stimulating hormone therapy: afamelanotide","volume":"12","author":"Fabrikant","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1053\/j.ackd.2013.09.004_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-47384-4_25","article-title":"Discovery and development of novel melanogenic drugs","volume":"11","author":"Hadley","year":"1998","journal-title":"Melanotan-I and -II. Pharm Biotechnol"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib57","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1743-6109.2007.00698.x","article-title":"Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study","volume":"5","author":"Safarinejad","year":"2008","journal-title":"J Sex Med"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ajpath.2011.03.042","article-title":"The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties","volume":"179","author":"Montero-Melendez","year":"2011","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"issue":"suppl 4","key":"10.1053\/j.ackd.2013.09.004_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1743-6109.2007.00610.x","article-title":"Bremelanotide: an overview of preclinical CNS effects on female sexual function","volume":"4","author":"Pfaus","year":"2007","journal-title":"J Sex Med"},{"issue":"63","key":"10.1053\/j.ackd.2013.09.004_bib61","first-page":"91","article-title":"Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH)","volume":"12","author":"Bomback","year":"2011","journal-title":"Discov Med"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.23341","article-title":"Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis","volume":"59","author":"Rouster-Stevens","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ackd.2013.09.004_bib63","first-page":"680A","article-title":"Treatment with synthetic ACTH in patients with idiopathic membranous nephropathy and high risk for renal failure","volume":"21","author":"Hofstra","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5414\/CNP62403","article-title":"ACTH therapy in nephrotic syndrome induced by idiopathic membranous nephropathy","volume":"62","author":"Picardi","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib65","first-page":"306A","article-title":"Treatment of idiopathic membranous nephropathy with ACTH is associated with a decline in anti-PLA2R antibody","volume":"20","author":"Beck","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib66","first-page":"33A","article-title":"Response of anti-PLA2R to adrenocorticotropic hormone (ACTH) gel in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib67","first-page":"58A","article-title":"A pilot study to determine dose, effectiveness and depletion of anti-PLA2R antibodies of adrenocorticotropic hormone (ACTH Acthar gel) in subjects with nephrotic syndrome and idiopathic membranous nephropathy (iMN)","volume":"23","author":"Hladunewich","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib68","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.4049\/jimmunol.175.7.4806","article-title":"Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status","volume":"175","author":"Cooper","year":"2005","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2013.09.004_bib69","unstructured":"Farnsworth EB. Studies on the influence of adrenocorticotrophin in acute nephritis, in simple nephrosis and in nephrosis with azotemia. In: Mote JR, ed. Proceedings of the First Clinical ACTH Congress. The Blakiston Company, Philadelphia, PA; 1950:297-317."},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib70","first-page":"152","article-title":"Management of nephrosis; the use of long continued hormone therapy","volume":"85","author":"Piel","year":"1956","journal-title":"Calif Med"},{"key":"10.1053\/j.ackd.2013.09.004_bib71","first-page":"725A","article-title":"Treatment of resistant primary focal segmental glomerulosclerosis (FSGS) with adrenocorticotropic hormone (ACTH) gel","volume":"23","author":"Hogan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2013.09.004_bib72","first-page":"941A","article-title":"Treatment of focal segmental glomerulosclerosis with ACTH","volume":"23","author":"Berg","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2013.09.004_bib73","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1097\/01.ASN.0000039661.06947.FD","article-title":"Podocyte biology and response to injury","volume":"13","author":"Mundel","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib74","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","article-title":"Inducible rodent models of acquired podocyte diseases","volume":"296","author":"Pippin","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib75","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI113145","article-title":"Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation","volume":"80","author":"Garcia","year":"1987","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.ackd.2013.09.004_bib76","first-page":"365A","article-title":"Use of ACTH gel in a patient with progressive nephrotic syndrome secondary to transplant glomerulopathy (TG)","volume":"23","author":"Patel","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"4790","key":"10.1053\/j.ackd.2013.09.004_bib77","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","article-title":"Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy)","volume":"2","author":"Symmers","year":"1952","journal-title":"Br Med J"},{"key":"10.1053\/j.ackd.2013.09.004_bib78","unstructured":"Berg AL, Back SE. ACTH treatment in patients with lupus nephritis. Paper presented at: National Kidney Foundation 2013 Spring Clinical Meetings; 2013; Poster\u00a0217."},{"key":"10.1053\/j.ackd.2013.09.004_bib79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1210\/me.2010-0217","article-title":"Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT","volume":"25","author":"Herraiz","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"1-3","key":"10.1053\/j.ackd.2013.09.004_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.regpep.2006.11.003","article-title":"Melanocortin-3 receptor activates MAP kinase via PI3 kinase","volume":"139","author":"Chai","year":"2007","journal-title":"Regul Pept"},{"issue":"1-2","key":"10.1053\/j.ackd.2013.09.004_bib82","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mce.2009.01.014","article-title":"Melanocortin 5 receptor activates ERK1\/2 through a PI3K-regulated signaling mechanism","volume":"303","author":"Rodrigues","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"1-3","key":"10.1053\/j.ackd.2013.09.004_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.regpep.2004.02.018","article-title":"Activation of MAP kinase by MC4-R through PI3 kinase","volume":"120","author":"Vongs","year":"2004","journal-title":"Regul Pept"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tibs.2006.03.009","article-title":"MAPK signal specificity: the right place at the right time","volume":"31","author":"Murphy","year":"2006","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-3083.2005.01565.x","article-title":"Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes","volume":"61","author":"Andersen","year":"2005","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1053\/j.ackd.2013.09.004_bib86","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbi.2008.06.001","article-title":"Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents","volume":"22","author":"Delgado","year":"2008","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nri1984","article-title":"Regulation of immune tolerance by anti-inflammatory neuropeptides","volume":"7","author":"Gonzalez-Rey","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1053\/j.ackd.2013.09.004_bib89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)81694-3","article-title":"IkappaB-NF-kappaB structures: at the interface of inflammation control","volume":"95","author":"Baeuerle","year":"1998","journal-title":"Cell"},{"issue":"12","key":"10.1053\/j.ackd.2013.09.004_bib90","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1074\/jbc.M710396200","article-title":"Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells","volume":"283","author":"Gong","year":"2008","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1053\/j.ackd.2013.09.004_bib91","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib92","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1440-1711.2001.01022.x","article-title":"In\u00a0vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH)","volume":"79","author":"Taylor","year":"2001","journal-title":"Immunol Cell Biol"},{"issue":"7880","key":"10.1053\/j.ackd.2013.09.004_bib93","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib94","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1523-1747.1998.00276.x","article-title":"Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model","volume":"111","author":"Scott","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1053\/j.ackd.2013.09.004_bib96","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1091\/mbc.9.6.1367","article-title":"Inhibition of Rho is required for cAMP-induced melanoma cell differentiation","volume":"9","author":"Busca","year":"1998","journal-title":"Mol Biol Cell"},{"issue":"6","key":"10.1053\/j.ackd.2013.09.004_bib97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.0954-6820.1973.tb10627.x","article-title":"Hypersensitivity to different ACTH peptides","volume":"193","author":"Forssman","year":"1973","journal-title":"Acta Med Scand"},{"issue":"6","key":"10.1053\/j.ackd.2013.09.004_bib98","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/0091-6749(87)90248-X","article-title":"Evaluation and management of corticotropin allergy","volume":"79","author":"Lee","year":"1987","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1053\/j.ackd.2013.09.004_bib99","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/jcem.83.6.4911","article-title":"Glucocorticoid effects on bone","volume":"83","author":"Reid","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.ackd.2013.09.004_bib100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00198-004-1616-3","article-title":"Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome","volume":"15","author":"Minetto","year":"2004","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2265.2000.01122.x","article-title":"Tall stature in familial glucocorticoid deficiency","volume":"53","author":"Elias","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"19","key":"10.1053\/j.ackd.2013.09.004_bib102","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1073\/pnas.0912176107","article-title":"ACTH protects against glucocorticoid-induced osteonecrosis of bone","volume":"107","author":"Zaidi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.ackd.2013.09.004_bib103","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorticoid inhibition of insulin secretion. An in\u00a0vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1053\/j.ackd.2013.09.004_bib104","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1172\/JCI66180","article-title":"New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it","volume":"122","author":"Ferris","year":"2012","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2337\/diab.16.7.449","article-title":"Insulin release after ACTH, glucagon and adenosine-3'-5'-phosphate (cyclic AMP) in the perfused isolated rat pancreas","volume":"16","author":"Sussman","year":"1967","journal-title":"Diabetes"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1800155","article-title":"ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans","volume":"180","author":"Al-Majed","year":"2004","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib107","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/endo-81-4-925","article-title":"Effect of administration of ACTH on insulin secretion in dogs","volume":"81","author":"Ohsawa","year":"1967","journal-title":"Endocrinology"},{"key":"10.1053\/j.ackd.2013.09.004_bib108","first-page":"678A","article-title":"Safety and efficacy of Acthar gel (ACTH) on albuminuria and progression of diabetic nephropathy in patients with nephrotic range proteinuria: A randomized prospective study","volume":"21","author":"Tumlin","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib109","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways","volume":"360","author":"Greenfield","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2013.09.004_bib110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(98)00230-2","article-title":"The role of corticosteroids in the regulation of vascular tone","volume":"41","author":"Ullian","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib111","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","article-title":"Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension","volume":"13","author":"Frey","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"10.1053\/j.ackd.2013.09.004_bib112","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1210\/jcem.84.12.6256","article-title":"Glucocorticoid-remediable aldosteronism","volume":"84","author":"Dluhy","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ackd.2013.09.004_bib113","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"issue":"5959","key":"10.1053\/j.ackd.2013.09.004_bib114","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/308544a0","article-title":"Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones","volume":"308","author":"Sheppard","year":"1984","journal-title":"Nature"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib115","first-page":"3239","article-title":"Increased experimental metastatic capacity of a murine melanoma following induction of differentiation","volume":"46","author":"Bennett","year":"1986","journal-title":"Cancer Res"},{"issue":"7","key":"10.1053\/j.ackd.2013.09.004_bib116","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/ijc.25804","article-title":"Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden","volume":"129","author":"Williams","year":"2011","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1053\/j.ackd.2013.09.004_bib117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1194\/jlr.R700015-JLR200","article-title":"Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe?","volume":"49","author":"Smith","year":"2008","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1053\/j.ackd.2013.09.004_bib118","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2009-0037","article-title":"The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology","volume":"31","author":"Tao","year":"2010","journal-title":"Endocr Rev"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559513001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559513001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:27:06Z","timestamp":1716564426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559513001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1548559513001432"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2013.09.004","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}